Le Lézard
Classified in: Science and technology
Subject: ACC

Repurchases of shares by EQT AB during week 18, 2024


STOCKHOLM, May 6, 2024 /PRNewswire/ -- Between 29 April 2024 and 3 May 2024 EQT AB (LEI code 213800U7P9GOIRKCTB34) ("EQT") has repurchased 338,244 own ordinary shares (ISIN: SE0012853455).

The repurchases form part of the repurchase program of a maximum of 2,154,000 own ordinary shares for a total maximum amount of SEK 1,000,000,000 that EQT announced on 22 April 2024. The repurchase program, which runs between 23 April 2024 and 24 May 2024, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 and the Commission Delegated Regulation (EU) No 2016/1052.

EQT ordinary shares have been repurchased as follows:

                                   

                                   

Date:

Aggregated daily
volume (number of
shares):

Weighted average
share price per day
(SEK):

Total daily
transaction value
(SEK):        

                                   

29 April 2024

 

95,659

 

299.2308

 

28,624,119.10

                                   

30 April 2024

 

59,252

 

300.3904

 

17,798,731.98

                                   

2 May 2024

 

89,365

 

296.0365

 

26,455,301.82

                                   

3 May 2024

 

93,968

 

302.9461

 

28,467,239.12

                                   

Total accumulated over week 18/2024

 

338,244

 

299.6221

 

101,345,392.03

                                   

Total accumulated during the repurchase program

 

736,778

 

297.2848

 

219,032,875.57

All acquisitions have been carried out on Nasdaq Stockholm by Skandinaviska Enskilda Banken AB on behalf of EQT.

Following the above acquisitions and as of 3 May 2024, the number of shares in EQT, including EQT's holding of own shares is set out in the table below.


Ordinary shares

Class C shares1

Total                        

                                   

Number of issued shares

 

1,245,048,412

 

881,555

 

1,245,929,967

                                   

Number of shares owned by EQT AB2

 

61,211,607

 

-

 

61,211,607

                                   

Number of outstanding shares

 

1,183,836,805

 

881,555

 

1,184,718,360

1) Carry one tenth (1/10) of a vote.
2) EQT AB shares owned by EQT AB are not entitled to dividends or carry votes at shareholders' meetings.

A full breakdown of the transactions is attached to this announcement.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15 
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/repurchases-of-shares-by-eqt-ab-during-week-18--2024,c3974245

The following files are available for download:

https://mb.cision.com/Main/87/3974245/2780940.pdf

EQT - Repurchases of shares - Weekly press release w18

https://news.cision.com/eqt/i/eqt-ab-group,c3297061

EQT AB Group

https://mb.cision.com/Public/87/3974245/813e948bab504aec.pdf

EQT Transactions Week 18


These press releases may also interest you

18 mai 2024
Reality TV Star, Mollie Pearce, Backs Campaign to Tackle Inequalities in Condition That Impacts Millions of People Globally
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
Industrial Automation Market In Life Sciences Industry size is set to grow by USD 5.06 bn from 2024-2028, growing global demand for healthcare services to boost the market growth, Technavio
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
Ibbaka Revenue Retention Maturity Model Helps B2B SaaS Companies Uncover Hidden Opportunities Within Customer Revenue Growth
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals' LIVMARLI Data Showcased at ESPGHAN Annual Meeting
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

18 mai 2024
After Launching Massive Camp Giveaway for NYC Families Affected by "Summer Rising" Crisis, Brains & Motion Education (BAM!) Extends Initiative to SF Bay Area Families
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...

More news about Science and technology...


News published on and distributed by: